Drug intelligence / Profile preview

Scutellaria lateriflora

Development stage
Unknown
Modality
Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules, Classical Binding Small Molecules → Small Molecules
Administration
Oral, Topical
01

Overview

*Scutellaria lateriflora*, commonly known as American skullcap, is a perennial herb native to North America traditionally used in herbal medicine for its sedative, anxiolytic, and anticonvulsant properties. Its therapeutic effects are primarily attributed to a diverse profile of flavonoids, including baicalin, baicalein, wogonin, and oroxylin A. Recent clinical and preclinical research has explored its efficacy in treating primary insomnia, managing stress-induced cortisol release, and reducing gingival inflammation when used in combination with other botanical extracts. Additionally, its constituent flavonoids have demonstrated potential anti-inflammatory, antioxidant, and neuroprotective activities, with investigations extending into oncology (e.g., breast cancer and leukemia) and bone health. It is often administered as an aqueous or hydroethanolic extract in dietary supplements or homeopathic preparations.

Other names
American skullcapblue skullcapMad-dog skullcapScutellaria lateriflora L.
02

Targets

HTR7 (5-hydroxytryptamine receptor 7)BZD site (GABA-A receptor benzodiazepine site)PTGS2 (Prostaglandin-Endoperoxide Synthase 2)GABRA2 (Gamma-aminobutyric acid receptor subunit alpha 2)15-LOX (Lysyl Oxidase)MMP1 (Matrix metalloproteinase-1)MMP13 (Matrix metalloproteinase-13)MMP3 (Matrix metalloproteinase-3)TLR2 (Toll-like Receptor 2)JNK (Mitogen-activated protein kinase kinase kinase family)

Beyond the preview

Go deeper on Scutellaria lateriflora.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Scutellaria lateriflora.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call